UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported): November 4, 2010

CHINA SHESAYS MEDICAL COSMETOLOGY INC.
(Exact Name of Registrant as Specified in Charter)

Nevada 333-144888 01-0660195
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)

Sichuan SHESAYS Cosmetology Hospital Co., Ltd.
New No. 83, Xinnan Road, Wuhou District
Chengdu City, Sichuan Province, P.R. China 610041
(Address of Principal Executive Offices, including Zip Code)

Registrant’s telephone number, including area code: 86-028-8548-2277

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

  [  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  [  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  [  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  [  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 7.01. Regulation FD Disclosure.

On November 4, 2010, China SHESAYS Medical Cosmetology Inc. (the “Company”) issued a press release announcing that it recently opened a new outpatient clinic in Zigong city in Sichuan province. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.

The information contained in this Item 7.01 is not “filed” for purposes of the Securities Exchange Act of 1934, as amended, and is not deemed incorporated by reference by any general statements incorporating by reference this report or future filings into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent the Company specifically incorporates the information by reference. By including this Item 7.01 disclosure in the filing of this Current Report on Form 8-K and furnishing this information, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits
  Exhibit 99.1 Press Release.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CHINA SHESAYS MEDICAL
COSMETOLOGY INC.

Date: November 3, 2010
By: /s/ Yixiang Zhang
Name: Yixiang Zhang
Title: Chief Executive Officer


EXHIBIT INDEX
Form 8-K

    Filed
Exhibit                                                 By
No.                                                               Description Herewith Reference  
99.1 Press Release. X  


China SheSays Medical Co... (GM) (USOTC:CSAY)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more China SheSays Medical Co... (GM) Charts.
China SheSays Medical Co... (GM) (USOTC:CSAY)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more China SheSays Medical Co... (GM) Charts.